Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
2.470
-0.110 (-4.26%)
Nov 20, 2024, 4:00 PM EST - Market closed

Purple Biotech Statistics

Total Valuation

Purple Biotech has a market cap or net worth of $5.08 million. The enterprise value is -$898,074.

Market Cap 5.08M
Enterprise Value -898,074

Important Dates

The last earnings date was Friday, November 15, 2024, before market open.

Earnings Date Nov 15, 2024
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 319.69M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio 3.24
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.01.

Current Ratio 1.27
Quick Ratio 1.15
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -48.80

Financial Efficiency

Return on equity (ROE) is -34.39% and return on invested capital (ROIC) is -29.18%.

Return on Equity (ROE) -34.39%
Return on Assets (ROA) -24.97%
Return on Capital (ROIC) -29.18%
Revenue Per Employee n/a
Profits Per Employee -$582,900
Employee Count 20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -87.65% in the last 52 weeks. The beta is 0.38, so Purple Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.38
52-Week Price Change -87.65%
50-Day Moving Average 4.47
200-Day Moving Average 9.41
Relative Strength Index (RSI) 29.42
Average Volume (20 Days) 67,006

Short Selling Information

Short Interest 19,525
Short Previous Month 17,989
Short % of Shares Out 1.33%
Short % of Float n/a
Short Ratio (days to cover) 0.43

Income Statement

Revenue n/a
Gross Profit -196,000
Operating Income -16.05M
Pretax Income 18.76M
Net Income -11.66M
EBITDA -16.01M
EBIT -16.05M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has $6.30 million in cash and $222,000 in debt, giving a net cash position of $6.08 million.

Cash & Cash Equivalents 6.30M
Total Debt 222,000
Net Cash 6.08M
Net Cash Per Share n/a
Equity (Book Value) 29.47M
Book Value Per Share n/a
Working Capital 1.48M
Full Balance Sheet

Cash Flow

Operating Cash Flow -17.34M
Capital Expenditures n/a
Free Cash Flow -17.34M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Purple Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -229.29%
FCF Yield -340.94%

Analyst Forecast

The average price target for Purple Biotech is $126.50, which is 5,021.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target $126.50
Price Target Difference 5,021.46%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on September 17, 2024. It was a reverse split with a ratio of 0.05:1.

Last Split Date Sep 17, 2024
Split Type Reverse
Split Ratio 0.05:1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a